|Year : 2019 | Volume
| Issue : 3 | Page : 185-188
Early cholangitis after portoenterostomy in children with biliary atresia
Priya Ramachandran1, Mohamed Safwan2, Muthukrishnan Saravana Balaji3, Ashitha K Unny3, Anis Akhtarkhavari3, Vidya Tamizhvanan3, Mohamed Rela2
1 Department of Pediatric Surgery, CHILDS Trust Medical Research Foundation, Kanchi Kamakoti Childs Trust Hospital; Department of Liver Surgery and Transplantation, Institute of Liver Diseases and Transplantation, Gleneagles Global Health City, Chennai, Tamil Nadu, India
2 Department of Liver Surgery and Transplantation, Institute of Liver Diseases and Transplantation, Gleneagles Global Health City, Chennai, Tamil Nadu, India
3 Department of Pediatric Surgery, CHILDS Trust Medical Research Foundation, Kanchi Kamakoti Childs Trust Hospital, Chennai, Tamil Nadu, India
|Date of Web Publication||6-Jun-2019|
Dr. Priya Ramachandran
No. 10, Nageswara Road, Nungambakkam, Chennai - 600 038, Tamil Nadu
Source of Support: None, Conflict of Interest: None
| Abstract|| |
Aims and Objectives: Biliary atresia (BA) is a cholangiodestructive disease of the biliary tree. The first line of treatment is a Kasai portoenterostomy (PE) following which patients may develop cholangitis. We studied the effect of early cholangitis on the outcome of PE, namely jaundice clearance and early native liver survival (NLS).
Methods: We reviewed the data of all children who developed cholangitis after PE from our prospectively maintained database of children with BA. The standardized treatment of all children in the database is described. The frequency and nature of these episodes were characterized, and the outcome of PE and NLS 1 year after PE was calculated.
Results: Of 62 children who underwent PE in our institutions, 27 developed cholangitis. All episodes of cholangitis occurred within 14 months of PE. Of 25 children who cleared jaundice in the overall series, 19 had cholangitis. The incidence of cholangitis was significantly higher in children who cleared jaundice. Nine children who had cholangitis are alive with native livers for more than 1 year after PE. Twelve children had intractable cholangitis. Three of these children are alive with native liver 1 year after PE.
Conclusion: In our series, cholangitis occurred in most children who cleared jaundice. Furthermore, the 1-year NLS of children who developed cholangitis was 33%.
Keywords: Biliary atresia, cholangitis, portoenterostomy
|How to cite this article:|
Ramachandran P, Safwan M, Balaji MS, Unny AK, Akhtarkhavari A, Tamizhvanan V, Rela M. Early cholangitis after portoenterostomy in children with biliary atresia. J Indian Assoc Pediatr Surg 2019;24:185-8
|How to cite this URL:|
Ramachandran P, Safwan M, Balaji MS, Unny AK, Akhtarkhavari A, Tamizhvanan V, Rela M. Early cholangitis after portoenterostomy in children with biliary atresia. J Indian Assoc Pediatr Surg [serial online] 2019 [cited 2021 Apr 23];24:185-8. Available from: https://www.jiaps.com/text.asp?2019/24/3/185/259766
| Introduction|| |
In biliary atresia (BA), the intrahepatic and extrahepatic biliary ductular continuum is destroyed by an inflammatory and fibrotic process. A portoenterostomy (PE) described by Professor Morio Kasai is the first line of management in controlling this disease. However, more than half of the children require liver transplantation (LT) even after this procedure. Cholangitis is the most common complication that occurs after a PE. It has been postulated that cholangitis causes rapid progression of liver injury leading to cirrhosis. Recurrent attacks of cholangitis have been shown to be a prognostic marker for hastened liver failure leading to the early requirement of transplantation. The effect of early cholangitis (within 1 year of PE) on jaundice clearance has not been reported. In this study, we aimed to assess the impact of early cholangitis on the outcome of PE with regard to jaundice clearance and short-term native liver survival (NLS).
| Methods|| |
Since February 2013, we maintained a prospective database of children with BA who had undergone PE in our institution. All PEs were performed by a single surgeon, and the technique used was an extended Kasai PE. This technique involved creation of a 60 cm roux loop to facilitate biliary drainage. After dissection of the hepatic vasculature at the hilum and excision of the hilar plate, hepaticojejunostomy was performed as an anastomosis extending from the bifurcation of the right hepatic artery into anterior and posterior branches to the Rex confluence of the left portal vein with the obliterated umbilical vein. The postoperative care was standardized and all children received piperacillin/tazobactam intravenously at a dose of 100 mg/kg four times a day for 1 week. Oral steroids (prednisolone) were started on day 6 after the establishment of oral feeds at a dose of 5 mg/kg, which was tapered weekly to 0.5 mg/kg (6 weeks). Patients were discharged after 1 week and given cyclical antibiotics as prophylaxis, which included amoxicillin-clavulanic acid (40 mg/kg/day in two divided doses) and cefpodoxime (10 mg/kg/day in two divided doses). This was continued for 6 months. Cholangitis was diagnosed by (1) the occurrence of fever, pale stools, (2) elevated white cell count and C-reactive protein, and (3) with elevation of bilirubin and/or elevation of liver enzymes. Once the diagnosis of cholangitis was considered, we performed routine blood cultures in these patients after which they were admitted for administration of intravenous (IV) piperacillin–tazobactam. If there was no clinical improvement, we upgraded the antibiotics to meropenem. In children with intractable fever and persistent jaundice, even in the absence of a positive blood culture, we empirically added antifungals (amphotericin B). All children underwent endoscopy and/or variceal banding 1 year after PE.
For this study, data were collected on the incidence of cholangitis after PE, including number and nature of such episodes, jaundice clearance after PE, need for LT, and the duration of survival with native liver. Patients who presented with 1–2 episodes of cholangitis amenable to a course of IV antibiotics were characterized as having simple cholangitis. Intractable cholangitis involved multiple episodes of infection or an episode of infection requiring prolonged treatment with antibiotics and antifungals. The outcome of PE in children who had cholangitis was computed.
Continuous variables were expressed as means with standard deviation and analyzed with Student t-test. Discrete variables were expressed as percentages and were analyzed using the Chi-square test. P < 0.05 was considered statistically significant. All data were collected after approval from our institutional review board.
| Results|| |
During a 5-year period, from 2013 to 2018, 62 children underwent PE in our institution for BA. There was no perioperative mortality in our series. In this overall group, 25 (40%) children cleared jaundice and 27 (43%) developed cholangitis after PE. On comparing the incidence of cholangitis among those who cleared jaundice to those who did not, the occurrence of cholangitis was significantly higher in those who cleared (n = 19, 76%) compared to those who did not (n = 8, 22%) clear jaundice (P < 0.001) [Table 1]. The average age at the time of surgery of children who developed cholangitis was 84.4 ± 30.7 days compared to 77.3 ± 23.2 days (P = 0.30). The follow-up ranged from 3 to 51 months. Blood culture was positive in two patients ( Escherichia More Details coli). Three children in this group had biliary atresia splenic malformation (BASM).
Fourteen (51.8%) children had cholangitis within the 1st month after PE. All episodes occurred within the 1st year after PE except in one child who had an episode of cholangitis 14 months after PE. Twelve (44.4%) children had intractable cholangitis. All children responded to the treatment measures described above. Nine children who had PE more than 1 year ago and had cholangitis are alive with native liver. Thus, the overall NLS rate after 1 year in children who had cholangitis post PE was 33%. Three children with intractable cholangitis are alive with native liver at 1 year. Two children underwent LT for synthetic liver dysfunction. Both children did not clear jaundice after PE. All three children with BASM developed cholangitis. None of the children in this series had variceal bleeding.
| Discussion|| |
Recurrent cholangitis is an indication for LT even in children who achieve jaundice clearance. Our study showed a good 1 year NLS for children who cleared jaundice and developed cholangitis. Since most episodes of cholangitis occurred within the 1st year after PE, we feel that by managing these episodes effectively, we can improve the NLS and avoid or postpone LT.
The establishment of autoanastomosis between intrahepatic bile ducts and intestinal epithelium after a PE takes about 6 weeks. Hence, before this, the transected microscopic ducts in the hilum are susceptible to inflammation and closure. If the intrahepatic bile ducts do not drain well, cholangitis may occur either until good drainage is established or until the bile ducts undergo fibrosis. The incidence of cholangitis after a PE has been reported to range from 40% to 93%. The pathogens usually involved include intestinal flora such as E. coli, Pseudomonas aeruginosa, Enterobacter cloacae, Acinetobacter baumani, and Salmonella More Details typhi. These pathogens translocate from the intestine into the liver from the enteric conduit and proliferate causing inflammation and obstruction to bile drainage., This translocation is more common in the presence of obstructive jaundice probably due to sluggish bile flow. In some cases, patients develop cystic dilation of the intrahepatic bile ducts and become prone to recurrent episodes of cholangitis due to bile stasis in the cavities.
Multiple surgical and postoperative management approaches to prevent cholangitis have been reported. Surgical modifications to the original Kasai operation to prevent the occurrence of cholangitis have included exteriorization of the bilioenteric loop and creation of an intussusception type antireflux valve to prevent reflux. However, these alterations are not currently in use because they have not proven to be effective and result in complications such as electrolyte imbalance and bleeding due to portal hypertension., Steroids have been known to reduce the inflammation and improve bile flow during episodes of cholangitis. A short burst of steroids as an adjunct to antibiotics in intractable cholangitis has been proved to be extremely successful. Second- and third-generation cephalosporins have been used to treat cholangitis sometimes in conjunction with aminoglycosides. Meropenem has also been effectively used for treatment. Prophylactic antibiotics prevent recurrent bouts of cholangitis. Recently, IV immunoglobulin has also been used to treat intractable cholangitis. Lactobacillus casei was effective in preventing cholangitis in patients after PE.
Some studies have reported that good postoperative bile drainage and jaundice clearance is associated with a lower risk of cholangitis. This has not been our experience. In our series, the incidence of cholangitis was significantly higher in children who cleared jaundice compared to those who did not. It is probable that the opening up of drainage channels during PE might cause sluggish bile fl ow initially which if coupled with translocation of intestinal pathogens into the liver leads to an infection. Fifty percent of children had early cholangitis within 1 month after PE which corroborates the fact that infection occurs before establishment of drainage channels which commonly takes about 6 weeks. Although it has been reported that cholangitis within 3 months of PE was a negative prognostic factor for NLS, 33% of children who developed cholangitis in our series are alive with native liver for more than 1 year after PE.
Studies have reported that increased number of cholangitis episodes was predictive of a poor PE outcome. It has been reported that recurrent cholangitis leads to a greater probability of cirrhosis and early transplantation., In our series, 40% of children had intractable cholangitis and 3 of them are alive with native liver at 1 year.
Cholangitis as a late complication has been reported in long-term survivors of PE. Further follow-up of our patients is needed to look at long-term NLS in children who develop early cholangitis after PE for BA as well as to chronicle the later episodes of cholangitis which might occur in long-term survivors of PE.
| Conclusion|| |
Cholangitis occurred predominantly in children who cleared jaundice in our series and these children obtained a 33% 1-year NLS. Since these episodes generally decrease 1 year after PE, we feel that if we optimize the management during this period, some of these children may survive with native livers and may never require an LT. Prevention of cholangitis with a long Roux-en-Y loop, routine use of postoperative steroids, prolonged antibiotic prophylaxis, and aggressive management of infection with antibiotics might lead to improved NLS.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Chen SY, Lin CC, Tsan YT, Chan WC, Wang JD, Chou YJ, et al.
Number of cholangitis episodes as a prognostic marker to predict timing of liver transplantation in biliary atresia patients after Kasai portoenterostomy. BMC Pediatr 2018;18:119.
Luo Y, Zheng S. Current concept about postoperative cholangitis in biliary atresia. World J Pediatr 2008;4:14-9.
Wu ET, Chen HL, Ni YH, Lee PI, Hsu HY, Lai HS, et al.
Bacterial cholangitis in patients with biliary atresia: Impact on short-term outcome. Pediatr Surg Int 2001;17:390-5.
Hsieh CS, Huang LT, Huang CC, Wu JJ, Chuang JH. Bacteria ascend to liver from the bilioenteric conduit after choledochojejunostomy in the cholestatic rat. Pediatr Surg Int 2003;19:699-702.
Chuang JH, Lee SY, Chen WJ, Hsieh CS, Chang NK, Lo SK, et al.
Changes in bacterial concentration in the liver correlate with that in the hepaticojejunostomy after bile duct reconstruction: Implication in the pathogenesis of postoperative cholangitis. World J Surg 2001;25:1512-8.
Kawarasaki H, Itoh M, Mizuta K, Tanaka H, Makuuchi M. Further observations on cystic dilatation of the intrahepatic biliary system in biliary atresia after hepatic portoenterostomy: Report on 10 cases. Tohoku J Exp Med 1997;181:175-83.
Wildhaber BE. Biliary atresia: 50 years after the first Kasai. ISRN Surg 2012;2012:132089.
Kobayashi H, Yamataka A, Koga H, Okazaki T, Tamura T, Urao M, et al.
Optimum prednisolone usage in patients with biliary atresia postportoenterostomy. J Pediatr Surg 2005;40:327-30.
Wong KK, Fan AH, Lan LC, Lin SC, Tam PK. Effective antibiotic regime for postoperative acute cholangitis in biliary atresia – An evolving scene. J Pediatr Surg 2004;39:1800-2.
Bu LN, Chen HL, Chang CJ, Ni YH, Hsu HY, Lai HS, et al.
Prophylactic oral antibiotics in prevention of recurrent cholangitis after the Kasai portoenterostomy. J Pediatr Surg 2003;38:590-3.
Li D, Wang P, He Y, Jiao C, Zhuansun D, Wei N, et al.
Intravenous immunoglobulin for the treatment of intractable cholangitis after Kasai portoenterostomy in biliary atresia patients. Pediatr Surg Int 2018;34:399-404.
Lien TH, Bu LN, Wu JF, Chen HL, Chen AC, Lai MW, et al
. Use of Lactobacillus casei rhamnosus
to prevent cholangitis in biliary atresia after Kasai operation. J Pediatr Gastroenterol Nutr 2015;60:654-8.
Ernest van Heurn LW, Saing H, Tam PK. Cholangitis after hepatic portoenterostomy for biliary atresia: A multivariate analysis of risk factors. J Pediatr 2003;142:566-71.
Nakajima H, Koga H, Okawada M, Nakamura H, Lane GJ, Yamataka A, et al.
Does time taken to achieve jaundice-clearance influence survival of the native liver in post-Kasai biliary atresia? World J Pediatr 2018;14:191-6.
Wildhaber BE, Coran AG, Drongowski RA, Hirschl RB, Geiger JD, Lelli JL, et al.
The Kasai portoenterostomy for biliary atresia: A review of a 27-year experience with 81 patients. J Pediatr Surg 2003;38:1480-5.
Lünzmann K, Schweizer P. The influence of cholangitis on the prognosis of extrahepatic biliary atresia. Eur J Pediatr Surg 1999;9:19-23.
Nio M, Sano N, Ishii T, Sasaki H, Hayashi Y, Ohi R, et al.
Cholangitis as a late complication in long-term survivors after surgery for biliary atresia. J Pediatr Surg 2004;39:1797-9.